Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Etoposide Doxorubicin Cisplatin

Mixed Results for New Tx in Adrenal Cancer

Patients with advanced adrenocortical carcinoma lived no longer when standard therapy was combined with three-agent chemotherapy, but had a significantly higher response rate and progression-free survival (PFS), results of a large multicenter study showed.

Overall survival improved by almost 3 months with etoposide-doxorubicin-cisplatin (EDP) chemotherapy plus mitotane when compared with mitotane plus streptozocin, but… Mixed Results for New Tx in Adrenal Cancer   



trisomy1 - new england journal of medicine2 - neurological disorder1 - annual screening1 - kidney care1 - nongonococcal urethritis2 - lithium1 - tea consumption1 - heart disease9 - circumcision3 - rennin-angiotensin system1 - short-term hormone therapy1 - docetaxel1 - urine is sterile1 - diuretics1 - kidney donors2 - early-stage cancer1 - acute kidney injury biomarker1 - ct3 prostate cancer1 - hemorrhagic inflammation1 - trichomoniasis1 - urogenital sphincter1 - av fistula1 - kidney dysfunction1 - prostate imaging1 - cancerous prostate cells1 - hot flashes2 - androgenic stimulation1 - cnc1 - high-precision surgical robot1 -